Pulmonary Disposition of TR-700 Following Once-Daily Oral 200 mg

Clinical trial NCT01271998 · COMPLETED

Trial details

NCT number: NCT01271998
Sponsor: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bacterial Infection

Start date: 2010-12-08
Primary completion: 2011-01-03
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.